The Envision Healthcare/AmSurg merger’s wait period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired. The wait period pertains to the Federal Trade Commission’s review of the proposed merger between the two parties. AmSurg and Envision separately received a request for information from the antitrust division of the State of Florida Attorney General’s office. Both organizations are cooperating with the request.
Surgery Partners’ same-facility revenues totaled $279.7 million during the second quarter, up 14.9 percent from $243.5 million during the same period in 2015.
Tenet Healthcare shares increased 2.58 percent on Sept. 7. Tenet has a 52-week high of $49.06 and 52-week low of $21.39.
Nobilis Health’s total cash was $18.8 million and accounts receivable was $77.6 million during the second quarter.
During the week of Sept. 6 to Sept. 9, Hospital Corporation of America shares fell 0.7 percent, hitting $75.94 per share.
If you have a question, issue or note to suggest on an ASC management and development company please contact Mary Rechtoris at mrechtoris@beckershealthcare.com.
More articles on surgery centers:
Yearlong CON battle over Green Mountain Surgical Center continues — 5 things to know
8 hospitals, health systems opening or planning ASCs — August 2016
AmSurg-Envision merger closer to final stages as Hart-Scott-Rodino waiting period expires: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.